Alesco Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Alesco Advisors's LLY Position: Q2 2026 in Review
Alesco Advisors reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $7.15K and leaving 456 shares worth $547K. The position accounts for 0.01% of the portfolio, ranked #154.
Alesco Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Alesco Advisors held 456 shares of Eli Lilly worth $547K as of Q2 2026.
- Alesco Advisors sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
- Eli Lilly made up 0.01% of Alesco Advisors's portfolio in Q2 2026, its #154 holding.
- Alesco Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Alesco Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.